Attendees celebrated the accomplishments of a 10-year collaboration leading to the first patients treated in 2025 -- The first clinical trial at the HUS BNCT facility is nearing completion HELSINKI ...
A new boron agent drastically improves the effectiveness of boron neutron capture therapy for glioblastoma, demonstrate researchers at Tokyo Tech. The agent is selectively absorbed by brain tumor ...
HELSINKI and BOSTON, May 16, 2025 /PRNewswire/ -- Neutron Therapeutics LLC and the Helsinki University Hospital announce that they have treated the first cancer patients in a European hospital with ...
The neutron irradiation system includes a negative ion, electrostatic, tandem accelerator-based neutron source and proven lithium target technology to generate a clinically optimal neutron spectrum ...
A cancer treatment involving irradiated boron isotopes has been explored as a therapeutic option for several decades but with very little clinical success. But thanks to recent advances in technology, ...
Induction chemotherapy with docetaxel, cisplatin and cetuximab versus docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced or inoperable squamous cell ...
BOSTON & LJUBLJANA, Slovenia--(BUSINESS WIRE)--Neutron Therapeutics, a targeted radiation therapy company developing a comprehensive solution for Boron Neutron Capture Therapy (BNCT), and Cosylab, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results